Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Brimarafenib by MapKure for Colorectal Cancer: Likelihood of Approval
Brimarafenib is under clinical development by MapKure and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...
Brimarafenib by MapKure for Metastatic Colorectal Cancer: Likelihood of Approval
Brimarafenib is under clinical development by MapKure and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase...
Brimarafenib by MapKure for Solid Tumor: Likelihood of Approval
Brimarafenib is under clinical development by MapKure and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
Brimarafenib by MapKure for Pancreatic Cancer: Likelihood of Approval
Brimarafenib is under clinical development by MapKure and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...